>>reporter: IF ANY OF THE NINE LEADING COVID-19 VACCINES PROVE EFFECTIVE,
EFFECTIVE, THE WORLD IS IN FOR EFFECTIVE, THE WORLD IS IN FOR A
NEW LIKELY CHAOTIC RACE.
>> President Donald Trump: I AM
PROUDLY PUTTING AMERICA FIRST,
JUST AS YOU SHOULD BE PUTTING
YOUR COUNTRIES FI
JUST AS YOU SHOULD BE PUTTING YOUR COUNTRIES FIRST.
>> Reporter: VACCINE NA
YOUR COUNTRIES FIRST. >> Reporter: VACCINE NATIONALISM
IS EVERY COUNTRY FOR ITSELF,
WEALTHIER NAT
IS EVERY COUNTRY FOR ITSELF, WEALTHIER NATIONS BUYING UP
VACCINE SUPPLIES, LEAVING LITTLE
BEHIND FOR THE REST OF THE
WORLD.
WORLD.
WORLD. >>
WORLD. >> Prime Minister Trudeau: THIS
AGREEMENT SECURES UP TO 20
MILLION DOSES FOR CANADIANS.
>> Reporter: SCIENTISTS WARN
IT'S A DANGEROUS PA
>> Reporter: SCIENTISTS WARN IT'S A DANGEROUS PATH.
MODELS PREDICT THAT IF RICH
COUNTRIES MONOPOLIZE COVID-19
VACCINES INSTEAD OF DISTRIBUTING
THEM EQUALLY, IT COULD CAUSE
TWICE AS MANY DEATHS.
>> WHAT THAT REALLY MEANS IS
THAT PEOPLE WILL UNNECESSARILY
DIE.
DIE.
DIE. >>
DIE. >> Reporter: FORMER WHI
DIE. >> Reporter: FORMER WHITE HOUSE
HEALTH POLICY ADVISOR D
>> Reporter: FORMER WHITE HOUSE HEALTH POLICY ADVISOR DR. ZEKE
MANUAL SAYS THE U.S. IS GOING IT
ALONE AND BUYING UP VACCINE
DOSES, BUT IN S
ALONE AND BUYING UP VACCINE DOSES, BUT IN SOME WAYS SO IS
CANADA.
CANADA.
CANADA. >> CANADA'S PRE-BOUGHT, WHAT IS
IT, ABOUT SIX OR SEVEN TIMES ITS
POPULATION, SO WE NEED TO THINK
THROUGH THAT.
THROUGH THAT. IS THAT, YOU KNOW, A KIND OF
HOARDING.
HOARDING.
HOARDING. >> Reporter: EXPERTS SAY IT'S
ALSO DRIVING UP VACCINE PR
>> Reporter: EXPERTS SAY IT'S ALSO DRIVING UP VACCINE PRICES.
>> PERSONALLY, I THINK IT IS
IMPORTANT FOR CANADA TO BE
RESPONSIBLE FOR ITS PEOPLE.
>> Reporter: VIROLOGIST ALLISON
KELVIN IS ADVOCATING
MADE-IN-CANADA VACCINES AT A
PROMINENT LAB IN SASKATOON.
SHE WANTS CANADIANS VACCINATED
AS QUICKLY AS POSSIBLE,
BUT . . .
BUT . . .
BUT . . . >> THE PANDEMIC ISN'T GOING TO
END IF WE J
>> THE PANDEMIC ISN'T GOING TO END IF WE JUST PUT CANADA FIRST.
>> Reporter: THE WORLD HEALTH
ORGANIZATION WANTS TO ALLOW ALL
NATIONS TO QUICKLY VACCINATE
CERTAIN GROUPS THAT ARE AT HIGH
RISK OF S
CERTAIN GROUPS THAT ARE AT HIGH RISK OF SPREADING THE VIRUS.
ABOUT 90% OF THE WORLD'S
COUNTRIES H
ABOUT 90% OF THE WORLD'S COUNTRIES HAVE BOUGHT INTO THE
W.H.O.'S KOVACS PROGRAM,
INCLUDING CANADA.
INCLUDING CANADA. >> WITH COVID-19, NO ONE IS SAFE
UNTIL EVERYONE IS SAFE.
>> Reporter: BUT THE PROGRAM
ISN'T FULLY FUNDED YET, AND NOT
EVERYONE'S ON BOAR
ISN'T FULLY FUNDED YET, AND NOT EVERYONE'S ON BOARD.
CHINA IS STILL IN NEGOTIATIONS,
AND EXPERTS SAY THE U.S. WOULD
ONLY JOIN UNDER NEW LEADERSHIP.
>> YOU COULD TAKE THE VIEW THAT
YOUR POPULATION MIGHT LIKE YOU
BETTER IF YOU WERE THE ONE
GRABBING ALL THE VACCINE, BUT
YOUR POPULATION WON'T LOVE YOU
IF THE PANDEMIC'S GOING ON AND
ON AND ON.
>> Reporter: EQUITABLE
DISTRIBUTION WON'T BE EASY, BUT
GLOBAL HEALTH EXPERTS INSIST
VACCINE NATIONALISM IS
SELF-DEFEATING, DRIVING UP
PRICES, COSTING LIVES AND
ULTIMATELY PRO
PRICES, COSTING LIVES AND ULTIMATELY PROLONGING THIS
PANDEMIC.
PANDEMIC.
PANDEMIC. CHRISTINE BIRAK, CBC NEWS,
TORONTO.
TORONTO.
TORONTO. >> Andrew: NOW I WANT TO BRING
IN DR. ISAAC BOGOCH, INFECTIOUS
DISEASES SPECIALIST, BECAUSE
DOCTOR, EQUITABLE DISTRIBUTION,
A GOOD THING, I THINK WE ALL GET
THAT, BUT HOW CONFIDENT ARE YOU
THAT CANADA WILL HAVE ACCESS,
ENOUGH ACCESS TO A VACCINE,
GIVEN ALL THE HURDLES INVOLVED?
WE DON'T EVEN KNOW WHICH
CANDIDATES WILL WORK.
>> YEAH, THAT'S A REALLY GOOD
POINT IN THAT MANY OF THESE
CANDIDATE VACCINES MIGHT NEVER
MAKE IT TO MARKET.
THEY J
MAKE IT TO MARKET. THEY JUST MIGHT NOT BE
SUCCESSFUL IN P
THEY JUST MIGHT NOT BE SUCCESSFUL IN PHASE THREE
CLINICAL TRIALS.
CLINICAL TRIALS. CERTAINLY WE HAVE SO MANY STICKS
IN THE FIRE, SOME OF THESE ARE
GOING TO WORK OUT AND WE
CERTAINLY WILL BE ABLE TO ROLL
OUT ONE OR MAYBE TWO S
CERTAINLY WILL BE ABLE TO ROLL OUT ONE OR MAYBE TWO SUCCESSFUL
VACCINES, PROBABLY BY EARLY
2021.
2021.
2021. BUT
2021. BUT OF COURSE NO ONE COULD BE
100% CERTAIN IN THIS ERA.
>> Andrew: LOGISTICALLY, HOW
COMPLICATED IS IT TO ROLL IT
OUT, AND WHAT DO YOU EXPECT THAT
TO LOOK LIKE IN CANA
OUT, AND WHAT DO YOU EXPECT THAT TO LOOK LIKE IN CANADA?
>> SO IN CANADA I THINK THERE'S
GOING TO BE PRIORITIZATION OF
HIGHER-RISK GROUPS, THOSE WHO
ARE AT GREATER RISK OF HAVING
SEVERE INFECTION OR THOSE PEOPLE
AT GREATER RISK OF ACQUIRING
THIS INFECTION.
THIS INFECTION. AND OF COURSE THERE'S GOING TO
BE CHALLENGES.
BE CHALLENGES. MOST OF THESE VACCINES ARE
TWO-DOZE SERIOUS, AND THEN
THERE'S COLD CHANGE ISSUES.
MOST OF THEM HAVE TO BE STORED
AT VERY COLD SUB-ZERO
TEMPERATURES.
TEMPERATURES. THERE ARE GOING TO BE LOGISTICAL
CHALLENGES ASSOCIATED WITH IT,
BUT NOTHING THAT WE CAN'T TAKE
CARE OF IN CANADA.
>> Andrew: AND I HAVE TO CLOSE
WITH A CRYSTAL BALL QUESTION.
WHAT'S THE TIMELINE?
I MEAN, I WANT TO ASK YOU THIS
QUESTION EVERY TIME I GET A
CHANCE TO TALK TO YOU.
>> IN ALL FAIRNESS, ANYTHING IS
UP IN THE AIR, BUT I WOULDN'T BE
SURPRISED IF WE S
UP IN THE AIR, BUT I WOULDN'T BE SURPRISED IF WE SEE VACCINE
ROLLOUT IN CANADA IN THE VERY,
VERY EARLY PART OF 2021, BUT OF
COURSE ANYTHING CAN HAPPEN, SO I
DON'T REALLY KNOW, BUT I'D BE
OPTIMISTIC FOR FEBRUARY, BUT
THAT'S JUST A GUESS.
>> Andrew: ALL RIGHT,
DR. BOGOCH, GOOD TO TALK TO YOU.
THANKS SO MUCH.
>>